Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease
Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan
Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan
View: Text | PDF
Research Article Autoimmunity Metabolism

Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease

  • Text
  • PDF
Abstract

Inborn errors of nucleic acid metabolism often cause aberrant activation of nucleic acid sensing pathways, leading to autoimmune or autoinflammatory diseases. The SKIV2L RNA exosome is cytoplasmic RNA degradation machinery that was thought to be essential for preventing the self-RNA–mediated interferon (IFN) response. Here, we demonstrate the physiological function of SKIV2L in mammals. We found that Skiv2l deficiency in mice disrupted epidermal and T cell homeostasis in a cell-intrinsic manner independently of IFN. Skiv2l-deficient mice developed skin inflammation and hair abnormality, which were also observed in a SKIV2L-deficient patient. Epidermis-specific deletion of Skiv2l caused hyperproliferation of keratinocytes and disrupted epidermal stratification, leading to impaired skin barrier with no appreciable IFN activation. Moreover, Skiv2l-deficient T cells were chronically hyperactivated and these T cells attacked lesional skin as well as hair follicles. Mechanistically, SKIV2L loss activated the mTORC1 pathway in both keratinocytes and T cells. Both systemic and topical rapamycin treatment of Skiv2l-deficient mice ameliorated epidermal hyperplasia and skin inflammation. Together, we demonstrate that mTORC1, a classical nutrient sensor, also senses cytoplasmic RNA quality control failure and drives autoinflammatory disease. We also propose SKIV2L-associated trichohepatoenteric syndrome (THES) as a new mTORopathy for which sirolimus may be a promising therapy.

Authors

Kun Yang, Jie Han, Mayumi Asada, Jennifer G. Gill, Jason Y. Park, Meghana N. Sathe, Jyothsna Gattineni, Tracey Wright, Christian A. Wysocki, M. Teresa de la Morena, Luis A. Garza, Nan Yan

×

Figure 4

Aberrant activation of the mTORC1 pathway in keratinocytes of germline keratinocyte-specific Skiv2l knockout mice.

Options: View larger image (or click on image) Download as PowerPoint
Aberrant activation of the mTORC1 pathway in keratinocytes of germline k...
(A) MA plot comparing gene expression of Skiv2lctl and Skiv2lfl/flK14-Cre (germline keratinocyte-specific Skiv2l knockout) P0 epidermis (n = 2 mice per genotype). Data are shown as average gene expression (log10 average FPKM) on the y axis and log2-fold change (Skiv2lfl/flK14-Cre [KO] versus Skiv2lctl) on the x axis, with direction of enrichment as indicated. Red dots, keratinization-related genes; orange squares, keratinocyte-associated DAMPs genes; purple triangles, inflammatory skin disease related genes. (B) Heatmap of DEGs of Skiv2lctl versus Skiv2lfl/flK14-Cre. n = 2 mice per genotype. (C) Reactome pathway analysis of DEGs of Skiv2lctl versus Skiv2lfl/flK14-Cre. Dashed line showing adjusted P value as 0.05. Pathways without statistical significance (adj. P value > 0.05) are shown in gray. Normalized enrichment score (NES) is shown with color bar (red, enriched in Skiv2lfl/flK14-Cre; green, enriched in Skiv2lctl). Circle size indicates number of genes in a gene set. (D) GSEA of Skiv2lctl and Skiv2lfl/flK14-Cre P0 epidermis RNA-seq data set. GSEA plot of hallmark mTORC1 signaling. (E) A heatmap showing gene expression of the mTORC1 pathway in Skiv2lctl and Skiv2lfl/flK14-Cre P0 epidermis. n = 2 mice per genotype. (F and G) Fluorescence immunohistochemistry analysis of p-S6 ribosomal protein (S235/236) and p-4E-BP1 (T37/46) in Skiv2lctl and Skiv2lfl/flK14-Cre P0 pup skin tissues (F). Dashed line, epidermal-dermal junction. Scale bar: 50 μm. Quantification of p-S6 or p-4E-BP1 fluorescence intensity per cell (>50 cells each genotype) is shown in (G). Unpaired 2-sided Student’s t test, ***P < 0.001. (H) Representative images showing enlarged keratinocyte cell size in Skiv2lfl/flK14-Cre P0 pup skin. Scale bar: 20 μm. The K14 immunofluorescence images of Skiv2lfl/fl and iSkiv2l–/– epidermis are crops of images shown in Figure 3H.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts